| Introductory Address | |
| The New Biology and Vaccine Research | p. 1 |
| Keynote Presentation | |
| Mucosal Immunity to Vaccines: Current Concepts for Vaccine Development and Immune Response Analysis | p. 3 |
| Oral Diseases and Host Immune Responses | |
| Prospects for Human Mucosal Vaccines | p. 13 |
| Bacterial Diseases of the Oral Tissues | p. 25 |
| Oral Virus Infections: The Potential for Gene Transfer in Treatment and Prevention | p. 35 |
| Update on Vaccines and Vaccine Development | |
| Bacterial Mucosal Vaccines | p. 43 |
| A General Overview of Viral Vaccine Development | p. 51 |
| Vaccines and the Mucosal Immune System | |
| An Update on the "Jennerian" And Modified "Jennerian" Approach to Vaccination of Infants and Young Children Against Rotavirus Diarrhea | p. 59 |
| Induction of Mucosal and Serum Immune Responses to a Specific Antigen of Periodontal Bacteria | p. 71 |
| IgA1 Proteases and Host-Parasite Relationships in the Oral Cavity | p. 83 |
| Transport of IgA Immune Complexes Across Epithelial Membranes: New Concepts in Mucosal Immunity | p. 91 |
| Effect of Mucosal Microenvironment on Immune Response to Viruses | p. 95 |
| Optimizing Mucosal and Systemic Immune Responses | |
| Induction of T Helper Cells and Cytokines for Mucosal IgA Responses | p. 107 |
| Cytokine Production and T Cell Receptor Expression by Salivary Gland T Cells and Intraepithelial T Lymphocytes for the Regulation of the IgA Response | p. 119 |
| Immunological Adjuvants | p. 133 |
| Delivery Systems and Immune Analysis | |
| Passive Immunity | |
| M Cell-Mediated Antigen Transport and Monoclonal IgA Antibodies for Mucosal Immune Protection | p. 143 |
| A Mechanism of Passive Immunization with Monoclonal Antibodies to a 185,000 M[subscript r] Streptococcal Antigen | p. 151 |
| Active Immunity | |
| Delivery of Antigens by Recombinant Avirulent Salmonella Strains | p. 165 |
| Use of Recombinant BCG as a Vaccine Delivery Vehicle | p. 175 |
| Vaccinia Virus Recombinants as Potential Herpes Simplex Virus Vaccines | p. 183 |
| Liposomes and Conjugate Vaccines for Antigen Delivery and Induction of Mucosal Immune Responses | p. 191 |
| Peroral Immunization With a Cholera Toxin-Linked Bacterial Protein Antigen and Synthetic Peptide | p. 199 |
| Peptomers as Vaccine Candidates | p. 209 |
| Target Antigen Selection and Vaccine Development | |
| Structural and Functional Studies of Herpes Simplex Virus Glycoprotein D | p. 217 |
| Molecular, Immunological and Functional Characterization of the Major Surface Adhesin of Streptococcus Mutans | p. 229 |
| Reactive Antigens of the Periodontopathic Bacterium Actinobacillus Actinomycetemcomitans | p. 243 |
| Immunization With Fimbrial Protein and Peptide Protects Against Porphyromonas Gingivalis-Induced Periodontal Tissue Destruction | p. 255 |
| Vaccine Development: Progression from Target Antigen to Product | p. 263 |
| Immunological Correlates of Protection | |
| Significance of Immune Responses to Oral Antigens in Dental Diseases | p. 273 |
| Laboratory Correlates of Protection and Protective Immunity to Bordetella Pertussis | p. 287 |
| Future Directions | |
| Challenges and Opportunities in Vaccine Research | p. 293 |
| Summary and Recommendations for Future Research | p. 301 |
| Speakers and Moderators | p. 315 |
| Author Index | p. 319 |
| Subject Index | p. 321 |
| Table of Contents provided by Blackwell. All Rights Reserved. |